Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 934 participants.

Also called NCT07526987

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 934 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07526987
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07526987. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-05 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis
Acronym
EMPHASIS-2
Condition
Ischaemic Stroke
Intervention (Drug)
Minocycline Hydrochloride Capsule (50 mg per capsule)
Intervention (Drug)
Placebo of Minocycline Hydrochloride Capsule (50 mg per capsule, containing 0 mg of minocycline)
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct07526987
Content hash
e9e2aa49c2006d4a99430b228f76cff23c2e28d2ec644728022257062788c13f